The human ELF3 gene displays a notable upregulation in human malignancies, associated with poor survival outcomes in HER2+ breast cancer patients [56] and poor diagnosis in patients with papillary thyroid cancer [57]. Here, ELF3 is linked to thyroid gland papillary carcinoma.